Andrew M. Ibrahim: AI in Stroke Care and the Evidence Gap in Healthcare Delivery
Andrew M. Ibrahim, Chief Clinical Officer and Surgeon-Scientist at Viz.ai, George D. Zuidema Professor at University of Michigan, shared on LinkedIn about a recent article published in Nature Medicine, adding:
”This Nature Medicine paper has been generating a lot of discussion, particularly around the claim that there is limited evidence that AI meaningfully improves healthcare delivery.
I agree with the broader concern – many AI tools are entering the market faster than high-quality evidence is being generated.
But I think it’s important not to overgeneralize.
There are already examples of AI tools in clinical use for several years (8+), with prospective and multi-site evidence showing measurable impact on care delivery and outcomes that are widely agreed upon:
JAMA Neurology (stepped-wedge, multi-site RCT)
AI-enabled stroke triage reduced door-to-groin time (~12 minutes) and was associated with a significant reduction in mortality.
JNNP / BMJ (multi-site, difference-in-differences)
AI implementation in stroke networks was associated with improved workflow efficiency, increased EVT utilization, and meaningful cost savings (~$3,600 per episode).
Journal of Vascular Surgery: Venous (retrospective, real-world)
AI-supported PE workflows were associated with reduced in-hospital mortality (8.4% → 2.2%) and faster time to treatment in a single health system.
It’s right to ask for more evidence, but we should also not overlook that many AI tools do have an existing evidence base.”
Title: Show us the evidence for the value of medical AI

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support